Suppr超能文献

转移性胸膜癌的生存情况及滑石粉胸膜固定术:125例报告

Survival and talc pleurodesis in metastatic pleural carcinoma, revisited. Report of 125 cases.

作者信息

Sanchez-Armengol A, Rodriguez-Panadero F

机构信息

Hospital Universitario Virgen del Rocío, Servicio de Neumología, Seville, Spain.

出版信息

Chest. 1993 Nov;104(5):1482-5. doi: 10.1378/chest.104.5.1482.

Abstract

STUDY OBJECTIVE

To find out whether patients with different types of metastatic pleural carcinomas have significant differences in survival, as related to pleural fluid glucose and pH. A second objective was to evaluate the outcome of talc poudrage for pleurodesis.

DESIGN

Cohort analytic prospective study; follow-up of patients from thoracoscopic diagnosis and evaluation to death.

SETTING

Pulmonary department at a referral medical center.

PATIENTS

One hundred twenty-five patients with metastatic pleural carcinoma diagnosed by thoracoscopy were evaluated prospectively. One patient was lost to follow-up.

INTERVENTIONS

Thoracoscopy was performed in every patient, with talc pleurodesis performed at the end of each procedure.

MEASUREMENTS AND RESULTS

On the same day as thoracoscopy or the previous day, glucose levels and pH of both the blood and pleural fluid were determined. The outcome of talc poudrage was that pleural effusions were controlled in 104 out of 119 patients (87 percent). Pleurodesis failed in 43 percent (6/14) of the patients with a pleural fluid pH lower than 7.20, as opposed to 9 percent (8/92) of failures in patients with a pH above this limit (p < 0.01). Average survival was as follows: nonsmall cell lung cancer (n = 40), 4.3 months (range, 1 to 15 months); small cell lung cancer (n = 8), 3.7 months (1 to 12 months); breast carcinoma (n = 30), 7.4 months (1 to 29 months); and ovarian carcinoma (n = 8), 9.4 months (1 to 29 months). There was a significant difference in survival between patients with breast carcinoma and patients with cancer not sensitive to chemotherapy (7.4 vs 4.7 months; p < 0.02), although the pleural tumor lesion rating was even greater in the first group. We found no significant differences between lung carcinomas and those from other origins. Patients with a low pleural fluid glucose level and low pH had significantly shorter survival than the group with high glucose and high pH levels (1.9 vs 5.7 months, respectively; p < 0.005).

CONCLUSIONS

We confirmed our previous data demonstrating poor survival in patients with pleural effusions with low glucose and pH levels. The outcome of talc pleurodesis correlated to these same parameters. These results apply to all kinds of metastatic pleural carcinomas.

摘要

研究目的

探究不同类型转移性胸膜癌患者的生存率是否因胸腔积液葡萄糖和pH值的不同而存在显著差异。第二个目的是评估滑石粉喷洒法胸膜固定术的效果。

设计

队列分析前瞻性研究;对患者从胸腔镜诊断和评估直至死亡进行随访。

地点

一家转诊医疗中心的肺部疾病科。

患者

对125例经胸腔镜诊断为转移性胸膜癌的患者进行前瞻性评估。1例患者失访。

干预措施

每位患者均接受胸腔镜检查,并在每次检查结束时进行滑石粉胸膜固定术。

测量指标与结果

在胸腔镜检查当天或前一天,测定血液和胸腔积液的葡萄糖水平及pH值。滑石粉喷洒法的效果是,119例患者中有104例(87%)的胸腔积液得到控制。胸腔积液pH值低于7.20的患者中,43%(6/14)胸膜固定术失败,而pH值高于此限值的患者中失败率为9%(8/92)(p<0.01)。平均生存时间如下:非小细胞肺癌(n = 40),4.3个月(范围1至15个月);小细胞肺癌(n = 8),3.7个月(1至12个月);乳腺癌(n = 30),7.4个月(1至29个月);卵巢癌(n = 8),9.4个月(1至29个月)。乳腺癌患者与对化疗不敏感的癌症患者的生存率存在显著差异(7.4对4.7个月;p<0.02),尽管第一组的胸膜肿瘤病变评级更高。我们发现肺癌患者与其他来源癌症患者之间无显著差异。胸腔积液葡萄糖水平低和pH值低的患者的生存时间明显短于葡萄糖水平高和pH值高的患者组(分别为1.9对5.7个月;p<0.005)。

结论

我们证实了之前的数据,即胸腔积液葡萄糖和pH值低的患者生存率较差。滑石粉胸膜固定术的效果与这些相同参数相关。这些结果适用于各种转移性胸膜癌。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验